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We assessed the extent to which healthcare providers at a large healthcare facility in Sweden screen for intimate partner violence
against women and the determinants of such screening. Data on frequency of screening, readiness to screen on many dimensions
(using the Domestic Violence Healthcare Provider Survey Scale), demographic and occupational characteristics were administered
electronically to 217 healthcare providers. We found that only 50% of participants had during the past 3 month screened for IPV
at least once, and screening activity was marked with inequalities in measured individual characteristics. Participants of female
gender and of doctor/nurse occupation were more likely to screen than male and midwife peers, respectively. Healthcare providers
whoperceivedhigheﬃcacyinhandlingIPVissues,lowfearsofoﬀendingclients,professionalpreparedness,andwithavailabilityof
support networks for IPV victims were more likely to screen for IPV. Implications of these ﬁndings for interventions are discussed.
1.Introduction
Intimate partner violence (IPV) is deﬁned as behaviours
within an intimate relationship that cause physical, sexual,
or psychological harm, including acts of physical aggres-
sion, sexual coercion, psychological abuse, and controlling
behaviours [1]. Though IPV is prevalent among both men
and women, its impact on abused women’s health is far more
pronounced and documented, prompting call for action
from reknown health researchers and organisations in a bid
to break the cycle of abuse. Women experiencing IPV suﬀer
a wide range of health complications resulting from physical,
sexual, and psychological assaults manifest in severe physical
injuries [2–4], reproductive health problems including ter-
minated pregnancies, undesired pregnancies and child loss
during infancy [5–7], symptoms of depression, anxiety and
posttraumatic stress disorder, and risky health behaviours
such as unhealthy feeding habits, substance abuse, alcohol-
ism, and suicidal behaviours [8–10].
A disturbing aspect of intimate partner violence is the
under usage of the healthcare system by abused women.
Despite the higher likelihood for morbidity, women expe-
riencing IPV when contrasted with nonabused peers use
community and healthcare services disproportionately and
exhibit a constricted contact with healthcare providers and
employers when compared with peers in nonabusive inti-
mate relationships [11, 12]. A recent WHO multicountry
studyof10countriesincludinglow,middle,andhighincome
countries [11], found fear of retaliation from the abuser and
stigmatizing attitudes from service providers and commu-
nity at large tohinder abusedwomenfromseeking sanctuary
from formal networks (e.g., healthcare). Instead, abused
women opt for redress in such situations from informal
networks (e.g., family and relatives) [13]. In Sweden, few
abused women trust the judiciary system and only one in
four is oﬀered assistance from relevant formal institutions
[14]. Overall, these ﬁndings could be a reﬂection of social
and institutional marginalisation of abused women and/or
the inability of formal institutions to assist IPV victims.
The healthcare system thus could play an important role to
reverse this notion through the institutional detection and2 ISRN Nursing
management of IPV (i.e., screening for IPV in healthcare set-
tings).
In medicine, screening refers to a strategy used in a pop-
ulation to detect a disease in individuals with or without
obvious signs or symptoms of that disease. In essence there-
fore, screening for IPV in healthcare is a systematic involve-
ment of healthcare workers in the detection of IPV among
clients who may or may not present with direct signs of
victimization/abuse. The discussion on whether IPV screen-
ing should be universal is ongoing as the evidential sup-
port for the beneﬁts of screening is little. However, self-
reports from women indicating that they are comfortable
responding to IPV-related inquiries in healthcare settings
[15] together with recent evidence suggesting that such in-
quiries may reﬂect positively on women’s satisfaction with
healthcare in general [16] underscore the importance of uni-
versal screening. In support of this argument, healthcare
professionals acknowledge that routine screening is likely to
improve identiﬁcation and management of IPV [17].
Despite consensus among stakeholders (i.e., women cli-
entsandhealthcarepractitioners)onthepotentialbeneﬁtsof
screening for IPV in healthcare, only about 8–10% of health-
care personnel routinely screen for the phenomena [18, 19],
suggesting barriers. The healthcare providers’ insuﬃcient
knowledge and training in screening could explain this dis-
crepancy [18, 20]. Other factors related to professional roles
governing the provider-client relations (e.g., mutual respect,
fearofoﬀendingclients)andhealthcareprovider’sindividual
attitudes towards IPV may inﬂuence screening for IPV in
healthcare [21, 22]. An assessment of how structural fac-
tors inherent in healthcare supplier/supply (e.g., healthcare
provider’s skills and capabilities in screening, training, their
attitudes towards IPV screening, and their access to support
systems to which victims can be referred) may aﬀect the
likelihood of screening for IPV is warranted. Moreover, stud-
ies on possible demographic and occupational factors that
may account for diﬀerences in the screening for IPV between
individual healthcare providers are few in general [21–23]
and lacking in the Swedish context. For example, it may
be hypothesised that female care providers are more prone
than male peers to inquire about IPV as they are more
likely to identify with the problem, being potential victims;
nurses may be more prone to inquire about IPV as they are
more often at the forefront of care provision; experienced
personale may be more likely to probe for IPV and so forth.
An assessment of how such factors are related to screening is
useful among other things for the identiﬁcation of potential
groups requiring further education in screening. Moreover,
such baseline data will inevitably inform the development
of training programs and screening protocols for IPV in
healthcare Sweden. As of current, screening for IPV is vol-
untary practice in most Swedish healthcare organisations,
as protocols for screening remain nonexistent. The current
study will set the foundation for the introduction and de-
velopment of routine screening in a healthcare facility in
Sweden.
The main objective of this study therefore is to estimate
the extent and predictors of screening in healthcare Sweden,
using data from a large healthcare facility. Speciﬁcally, the
following research questions will be tackled.
(i) TowhatextentdohealthcareprovidersscreenforIPV
in Sweden?
(ii) To whatextent do work-related factors(i.e.,availabil-
ity of referrals for IPV victims, perceived eﬃcacy in
screening, conﬂicting professional roles), individual
attitudes (e.g., blaming the victim), and occupation
(e.g., being a doctor or nurse) inﬂuence the likeli-
hood of screening for IPV?
(iii) To what extent do demographic factors (e.g., sex, age,
religion,beingofethnicmajority/minority)inﬂuence
the likelihood of IPV screening?
2. Methods
2.1. Study Settings, Design and Participants. The study was
based on a cross-sectional survey design carried out at three
departments (i.e., women’s clinic, emergency clinic, and
ambulatory department) of the S¨ odersjukhuset, Sweden, one
of the largest multidepartmental hospitals in the country.
The healthcare providers at the hospital have not previously
undergone any speciﬁc formal training in screening for IPV
among their female clients. Thus, IPV screening remains
undeﬁned in routine practice.
A total of 217 providers participated in the survey,
though 77% of them responded to the question on screening
for IPV (the outcome variable for this study). The eﬀective
sample for this study was thus 168 healthcare practitioners.
None respondents did not however diﬀer on demographic
and occupational characteristics from those who responded.
Table 1 provides information regarding demographic and
occupational distribution of the participants (eﬀective sam-
ple).
All employees at the above-mentioned departments were
oﬀered the opportunity to participate in this study through a
web survey accessible by all employees (i.e., the hospital has
an employee website accessible by all employees) The survey
was available on the website during the period June–August
of 2009. Information of the study was given by the respective
department heads and further emphasised on the website.
Voluntary participation was emphasised and informed con-
sent was given. Participants were informed that responding
to the questionnaire implied that they had consented to par-
take in the study.
2.2. Ethical Consideration. This study received ethical ap-
proval from the regional ethical review board. The aims and
relevance of the study were explained to the participants
and information on the same was oﬀered on the web. Vol-
untary participation was emphasised, privacy guaranteed,
and informed consent given. Participants’ responses were
anonymous.
2.3. Instrument Readaptation to Swedish Setting. The survey
tool was ﬁrst translated to the Swedish language, the ofﬁ-
cial language in the country, by a professional translator.ISRN Nursing 3
Table 1: Demographic and occupational characteristics of partici-
pants.
N %
Gender
Male 36 21
Female 132 79
Immigration status
Immigrant∗ 24 14
Swedish born 144 86
Marital status
Married/cohabiting 116 69
Single 35 21
Divorced/widower/widow 17 10
Staﬀ cadre∗∗
Doctor 25 16
Nurse 62 40
Nursing assistant 34 22
Midwife 26 17
Other 7 5
Department∗∗
Emergency 106 65
Women’s clinic 45 28
Ambulatory 12 7
Age
(mean (st.dev in brackets)) 41 years (10.0 years)
Years in service
(mean (st.dev in brackets)) 17 years (11.2 years)
N: number within category, %: proportion within category. ∗Born of
another nationality than Swedish. ∗∗Not all participants responded to these
inquiries. Thus total falls short of n = 168.
Another independent translator with good knowledge of
both languages then translated the Swedish translation back
to English. The authors, who master both languages, then
studied and scrutinised the translation and agreed to adopt
it with minor modiﬁcations. The team however also scruti-
nised the content of all 35 questions and their applicability
in the studied setting. All questions relating to probing about
IPV from the potential perpetrators (one of the subscales)
were excluded from this study, the reason being that the
organisation intends to introduce a screening protocol that
exclusively probes of IPV possibility only among potential
victims. There are no plans to probe of IPV issues from the
perpetrators for safety reasons. The subscale was thus
deemed irrelevant for the current sample and therefore ex-
cluded from the web survey.
2.4. Measures
2.4.1. Dependent Variable. The dependent variable in this
study was screening for IPV which was operationalized by
probing of participants how often they had during the past 3
months inquired of the possibility of IPV from their female
clients. IPV was deﬁned for participants as exposure to
physical, sexual, or psychological abuse. Examples of these
forms of abuse were given. Because the distribution of this
variable was grossly skewed to the left (i.e., about half of the
participantshadnotinquiredofIPVatallduringthisperiod)
a dichotomous variable was computed for further analysis of
predictors of screening as follows: 1 if screened for IPV at
least once, 0 otherwise.
2.4.2. Independent Variables. The Domestic Violence Health-
Care Provider Survey Scale (DVHSS) [21] was used to mea-
surework-relatedfactorshypothesisedtoinﬂuencescreening
behaviour. The instrument has previously been validated
with promising results in some countries including USA and
Nigeria [21, 24]. The questionnaire, in its original format, is
composed of the following 5 subscales, though only 4 of the
subscales were used in this study. These are the following.
(i) The perceived self-eﬃcacy subscale (4 items) which
assesses healthcare providers’ own perceived eﬃcacy
in inquiring about IPV from potential victims in
terms of having strategies for screening, time to
screen, conﬁdence to make referrals for victims, and
access to information on IPV management. Cron-
bach’s alpha testing for internal consistency for the
current sample was 0.74, indicating good internal
consistency.
(ii) Thesystemsupportsubscale(4items)assessinghealth-
care providers’ access to support from mental health
workers, social assistants, and community advocates.
Cronbach’s alpha testing for internal consistency for
the current sample was 0.68, indicating good internal
consistency.
(iii) The professional roles resistant/fear of oﬀending clients
subscale (7 items) assesses whether providers perceive
inquiries about IPV to conﬂict with professional
conductgoverningtheircommunicationwithclients.
Speciﬁcally, participants are probed on whether IPV
inquiry in their view is an invasion of patient privacy,
demeaning to patient, may provoke anger, oﬀensive,
not part of medical practice, none of their business.
Cronbach’s alpha testing for internal consistency for
the current sample was 0.68, indicating good internal
consistency.
(iv) Theblamevictimsubscale(8items)assessesproviders’
attitudes towards victims. Generally, participants are
probed on whether they feel victims are getting
something out of the abuse, choose to be victims
or deserve abuse, and whether victims personalities
and breaking of social norms are the cause of abuse.
Cronbach’s alpha testing for internal consistency for
the current sample was 0.76, indicating good internal
consistency.
Individual scores for each of the above scales range from
1–5.
Demographic variables included as independent variables
inthisstudywereage,sex,minoritystatus,maritalstatusand
religion, while occupational characteristics included depart-
ment, employment category, and years of experience.4 ISRN Nursing
2.5. Statistical Analysis
2.5.1. Data Cleansing. Prior to analyses, certain procedures
were carried out to clean data. First, only participants who
had responded to the question on IPV screening (the de-
pendent variable) were included. Second, Cronbach’s Alpha
testing for internal consistency of the subscales of the
DVHSS for the current sample was calculated. Third, the
DVHSS subscales were scored in accordance with previous
recommendations (i.e., individual means on each scale) [21]
and the resulting means checked for normality using the
skewnessstatisticanditsconﬁdenceinterval.Skewnessstatis-
tic of magnitude zero is an indication of perfect symmetry.
Individual means on the subscales followed a normal distri-
bution, thus conventional statistical methodology assuming
normality described below could be adopted.
2.5.2. Data Analysis. To respond to the research questions, a
number of statistical analyses were run. T-tests were used to
assess whether scores on the DVHSS diﬀered between partic-
ipantswhohadscreenedandthosewhohadnot.Tostudythe
association between continuous demographic/occupational
measures (i.e., age and working experience) and the dichoto-
mous outcome variable (i.e., screening or not) T-tests were
run. To study the association between categorical demo-
graphic/occupational measures (e.g., sex and employment
categories) and the dichotomous outcome variable (i.e.,
screening or not) Chi-square tests were run. Finally, to
assess the independent association between dependent and
independent variables logistic regressions analysis was run.
For all tests, statistical signiﬁcance was assumed at P<0.05.
StatisticalPackageforSocialSciences(SPSSversion19.0)was
used for all analyses.
3. Results
3.1. Extent of Screening and Bivariate Associations with Dem-
ographic/Occupational Factors. Of the 168 participants, 51%
(n = 86) had during the past 3 months screened for the
possibility of IPV among their female clients at least once.
As shown in Table 2, the likelihood of screening for IPV
at least once during the past month varied depending
oncertaindemographic/occupationalcharacteristics.Female
participants screened to a higher extent than male peers (P<
0.05) and midwives to a lower degree than other staﬀ cadres
(P<0.05). The diﬀerences in screening observed by marital
status, migrant status, department, age, and years in service
did not reach statistical signiﬁcance.
3.2. Bivariate Associations between Screening and Enabling
Work Factors. As indicated in Table 3, participants who
screened for IPV when contrasted with peers who did not
perceivedonaverageahigherself-eﬃcacy(P<0.001),higher
availability of a support network for IPV (P<0.01), and
lower conﬂicting professional roles and fears with regard
to IPV screening (P<0.05). The hypothesised association
between screening and victim blame did not reach statistical
signiﬁcance.
Table 2: Screening for IPV by demographic and occupational char-
acteristics of participants.
Number
screening (n) Proportion %
Gender∗
Male 12 34
Female 70 53
Immigration status
Immigrant 10 43
Swedish born 72 50
Marital status
Married/cohabiting 57 49
Single 15 43
Divorced/widower/widow 10 58
Staﬀ cadre∗
Doctor 14 56
Nurse 31 50
Nursing assistant 20 59
Midwife 7 27
Other 6 85
Department
Emergency 58 55
Women’s clinic 16 35
Ambulatory 4 33
Screened
Mean (SE)
Did not screen
Mean (SE)
Age (years) 41 (1.1) 40 (1.1)
Years in service 17 (1.2) 18 (1.3)
n:numberwithincategorythatscreened,%:proportionwithincategorythat
screened. S.E: Standard Error. ∗Denotes statistically signiﬁcant association
between screening and respective variable at P<0.05.
Table 3: Association between screening and DVHSS subscales.
Screened for IPV
Mean (SE)
Did not screen for IPV
Mean (SE)
Perceived
self-eﬃcacy∗∗∗ 3.79 (0.09) 3.04 (0.09)
System support∗∗ 3.52 (0.09) 3.10 (0.10)
Blame victim 1.67 (0.06) 1.57 (0.06)
Professional role
resistant/fear of
oﬀence∗
1.53 (0.05) 1.70 (0.06)
∗Denotes statistically signiﬁcant at P<0.05; ∗∗denotes statistically signifi-
cant at P<0.01; ∗∗∗denotes statistically signiﬁcant at P<0.001.
3.3. Independent Predictors of Screening for IPV. Variables
that were signiﬁcantly associated with IPV screening in the
bivariate analyses were considered as candidate variables for
multivariableanalysestoassesstheirindependentassociation
with the likelihood of screening. However, some of these
variables posed a risk for multicollinearity (i.e., high corre-
lation between self-eﬃcacy, system support, and professional
role resistant/fear of oﬀence) and could not therefore be
included in the same model. Thus, three diﬀerent regressionISRN Nursing 5
Table 4: Logistic regression showing predictors of IPV screening.
Model 1
odds-ratio (CI)
Model 2
odds-ratio (CI)
Model 3
odds-ratio (CI)
Gender
Female 1.00 1.00 1.00
Male 0.31 (0.11–0.84)∗ 0.32 (0.11–0.87)∗ 0.28 (0.10–0.77)∗
Staﬀ cadre
Doctor 1.00 1.00 1.00
Nurse 0.60 (0.21–1.75) 0.65 (0.23–1.83) 0.55 (0.20–1.55)
Nursing
assistant 0.75 (0.23–2.45) 0.81 (0.26–2.49) 0.79 (0.25–2.45)
Midwife 0.38 (0.09–1.53) 0.16 (0.04–0.60)∗ 0.21 (0.06–0.80)∗
Other 4.18 (0.38–45.51) 5.67 (0.53–59.83) 5.49 (0.52–57.18)
Self-eﬃcacy 2.33 (1.44–3.76)∗ NA NA
Professional
role/fear NA 0.49 (0.25–0.97)∗ NA
System support NA NA 1.33 (1.01–2.21)∗
Model R-square 0.25 0.18 0.16
CI denotes conﬁdence interval for odds ratio. CI excluding 1 is an indication of statistical signiﬁcance. NA: not included in model. ∗Denotes statistically
signiﬁcant at P<0.05.
models were run to avoid the problem as presented in
Table 4.
As indicated in Table 4, gender remained consistently
associated with screening even after control for other factors
(i.e., staﬀ cadre, self-eﬃcacy, professional role resistance, and
system support). Male participants were consistently less
likely to screen than female peers, as expressed by the odds
ratios and theirconﬁdenceintervals. Inmodels 2and 3, mid-
wives exhibited a lower likelihood of screening than did
doctors even after control for other factors. After controlling
f o rg e n d e ra n ds t a ﬀ cadres, the likelihood of screening for
IPV increased with increasing self-eﬃcacy (model 1), reduc-
ingprofessionalroleconﬂicts/fears(model2),andincreasing
availability of support networks (model 3).
The three models explained 25%, 18%, and 16%, respec-
tively, of the variation in IPV screening.
4. Discussion
We examined the extent and predictors of IPV screening
at a large health facility in Sweden using a cross-sectional
study design. About 50% of the participants reported having
inquired about the possibility of IPV from their female
clients at least once during the past three months. These
ﬁgures appear higher than what is reported in Kano Nigeria
[22], a low income setting, but still does not meet the ideal
level expected of screening activity. According to advocates
for IPV screening [1, 22], the practice should ideally be both
routine and universal, that is, personale should inquire of
the possibility of IPV of all their female clients routinely,
regardless of whether they show clear symptoms of abuse or
not. Following this strict protocol, one would have expected
to see much higher ﬁgures to assume routine screening.
The ﬁndings therefore call for systematic training in IPV
screening at the study context (i.e., S¨ odersjukhuset) and sim-
ilar health clinics in Sweden, if ideal goals for IPV screening
are to be met.
Screening activity was signiﬁcantly associated with dem-
ographicandoccupationalfactors.Femalehealthcareprofes-
sionals were more likely to screen for IPV than male col-
leagues, corresponding with hypotheses suggesting that
womenmaybemorepronetoscreenforIPVoutofsympathy
for fellow women. The ﬁndings could also be echoing pre-
vious work indicating that women patients may be more
prone to discuss IPV issues with female professionals [25].
Doctors and nurses appeared better placed than midwives to
inquire of IPV exposure. These ﬁndings signal inequalities
in readiness to screen with regard to profession and call for
a review of prevailing protocols on how to handle patients,
how such protocols diﬀer across diﬀerent staﬀ cadres, and
what inﬂuences such diﬀerence could have on IPV screening
a c t i v i t y .A si sp r e v i o u s l yr e c o m m e n d e d[ 26–28], there is a
need for formulation of clear guidelines on IPV screening
for clinicians. Such guidelines should however be sensitive
to the diﬀerences in professional roles that may deter/foster
screening activity.
Not surprisingly, healthcare providers who perceived
high eﬃcacy in handling IPV issues, low fears of oﬀending
clients,professionalpreparedness, andavailability ofsupport
networks (all with regard to IPV screening) were more likely
to screen for IPV. These ﬁndings corroborate work from
other settings [21, 22] and stress the need to tailor training
programmestoaddressfearsandpossibleroleconﬂictswhen
confrontedwithIPV-relatedinquiries.Inaddition,structural
improvementsbothwithinand/oroutsidethehealthcareset-
ting are warranted to improve healthcare providers’ knowl-
edge of the support networks available for them to refer IPV
victims. This could be achieved through further education,
provision of elaborate information on existing relevant or-
ganisations, and improved collaboration with community
and other relevant services that address abuse of women.
T h o u ght h es t u d yc o rr o bo ra t e ss o m ep r evi o u sw o rk sa n d
provides direction for the programming of IPV screening in6 ISRN Nursing
Sweden, some of its weaknesses deserve some acknowledge-
ment. First, the issue of selection bias cannot be totally ruled
out. It is diﬃcult to compare the characteristics of those who
responded to the web survey with those who did not. One
could question whether respondents were more likely to be
sympathetic to the subject at hand. If that was the case, then
our results concerning the extent of screening could be an
underestimate.Likewise,itis possible thatonlythecomputer
literate may have participated. Nonetheless, Sweden is a
highly computer-literate society and this to some extent dif-
fuses suspicions of any biases introduced by variations in
computer literacy in the study population, particularly given
that they comprise professionals predominantly. With the
same token, it is not known whether any diﬀerences that may
be signiﬁcant for screening are likely between those who
choose to work in the summer and those who do not, as
data was collected in the summer season. Finally, because of
its cross-sectional design the study can only conﬁrm associ-
ations but cannot draw casual inference. Notwithstanding,
these plausible weaknesses many ﬁndings are in line with
other works suggesting inequalities in screening activity due
to demographic, occupational, work-environmental, and
structural factors [18–25].
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